Evidence map›Paper›PMID 30422099›Full record

ArticleHIV clinical trials2018

Red blood cell distribution width as an easily measurable biomarker of persistent inflammation and T cell dysregulation in antiretrovirally treated HIV-infected adults.

Zao Zhang, Glen M Chew, Cecilia M Shikuma, Louie Mar A Gangcuangco, Scott A Souza, Bruce Shiramizu, Beau K Nakamoto, Ting Gong, Santhosh R Mannem, Brooks I Mitchell and 3 more

Abstract read
In one paragraph

Article in HIV clinical trials, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Zao Zhanga Hawaii Center for AIDS, University of Hawaii John A. Burns School of Medicine , Honolulu , HI , USA.ORCID 0000-0003-3552-8078
Glen M Chewc Department of Tropical Medicine , Medical Microbiology & Pharmacology, University of Hawaii John A. Burns School of Medicine , Honolulu , HI , USA.ORCID 0000-0001-6186-4353
Cecilia M Shikumaa Hawaii Center for AIDS, University of Hawaii John A. Burns School of Medicine , Honolulu , HI , USA.
Louie Mar A Gangcuangcoc Department of Tropical Medicine , Medical Microbiology & Pharmacology, University of Hawaii John A. Burns School of Medicine , Honolulu , HI , USA.
Scott A Souzaa Hawaii Center for AIDS, University of Hawaii John A. Burns School of Medicine , Honolulu , HI , USA.
Bruce Shiramizua Hawaii Center for AIDS, University of Hawaii John A. Burns School of Medicine , Honolulu , HI , USA.
Beau K Nakamotoa Hawaii Center for AIDS, University of Hawaii John A. Burns School of Medicine , Honolulu , HI , USA.ORCID 0000-0001-6506-9672
Ting Gongc Department of Tropical Medicine , Medical Microbiology & Pharmacology, University of Hawaii John A. Burns School of Medicine , Honolulu , HI , USA.
Santhosh R Mannemb The Queen's Medical Center , Honolulu , HI , USA.
Brooks I Mitchellc Department of Tropical Medicine , Medical Microbiology & Pharmacology, University of Hawaii John A. Burns School of Medicine , Honolulu , HI , USA.
Kalpana J Kallianpura Hawaii Center for AIDS, University of Hawaii John A. Burns School of Medicine , Honolulu , HI , USA.ORCID 0000-0002-9978-097X
Lishomwa C Ndhlovua Hawaii Center for AIDS, University of Hawaii John A. Burns School of Medicine , Honolulu , HI , USA.ORCID 0000-0001-5427-4187
Dominic C Chowa Hawaii Center for AIDS, University of Hawaii John A. Burns School of Medicine , Honolulu , HI , USA.ORCID 0000-0001-7395-038X
University of Hawaiʻi at Mānoa · USQueen's Medical Center · US

Funding

The Role of gp120 on Cardiovascular Disease in People Living with HIVU54MD007601 · NIMHD · UNIVERSITY OF HAWAII AT MANOA · PI Jerris Robert Hedges · 2017 to 2026
$59.5M
RESEARCH DESIGN AND BIOSTATISTICS COREU54MD007584 · NIMHD · UNIVERSITY OF HAWAII AT MANOA · PI HEDGES, JERRIS ROBERT, MOKUAU, NOREEN · 2012 to 2018
$21.1M
RESEARCH ETHICSU54RR026136 · NCRR · UNIVERSITY OF HAWAII AT MANOA · PI INAZU, JUDITH · 2010 to 2011
$8.5M
Role of Oxidative Stress and Inflammation in HIV Cardiovascular RiskR01HL095135 · NHLBI · UNIVERSITY OF HAWAII AT MANOA · PI SHIKUMA, CECILIA M. · 2008 to 2012
$4.5M
Cardiovascular autonomic function in HIV virologic failureK23HL088981 · NHLBI · UNIVERSITY OF HAWAII AT MANOA · PI CHOW, DOMINIC C · 2008 to 2011
$580k
NCRR NIH HHS U54 RR026136NHLBI NIH HHS K23 HL088981NHLBI NIH HHS R01 HL095135NIMHD NIH HHS U54 MD007584NIMHD NIH HHS U54 MD007601
6 · The paper itself

Abstract

backgroundChronic inflammation and immune dysfunction occur in human immunodeficiency virus (HIV)-infection despite stable antiretroviral therapy (ART). Red blood cell distribution width (RDW) has been shown to correlate with markers of inflammation in non-HIV conditions. The study objective was to determine associations between RDW with cellular markers of immune activation and immune dysfunction including soluble inflammatory mediators in ART treated HIV infection.

methodsWe performed a cross-sectional analysis of the Hawaii Aging with HIV-Cardiovascular study. RDW was defined as one standard deviation of RBC size divided by mean corpuscular volume multiplied by 100%. Correlations were analyzed between RDW, soluble inflammatory biomarkers and T cell activation (CD38 + HLA-DR+), senescence (CD28-CD57+), and immune exhaustion (PD-1, TIGIT, TIM-3 expression).

resultsOf 158 participants analyzed, median age was 50 years, duration of ART 12.6 years, virally suppressed 84.4%, and CD4 count 503 cells/mm3. Significant positive correlations were identified between RDW and soluble biomarkers including sICAM, IL-8, IL-6, SAA, TNF-α, sE-selection, fibrinogen, D-dimer, CRP, CD4/CD8 ratio, and frequency of multiple CD8 T-cell populations such as CD38 + HLA-DR + T-cells, single TIGIT+, and dual expressing of TIGIT + PD1+, TIGIT + TIM3+, and TIM3 + PD1+ CD8+ T-cell subsets (p < .05). Frequencies of CD38 + HLA-DR + CD8+ T-cells and TIGIT + CD8+ T-cells remained significant adjusting for baseline variables (p < .01).

conclusionOur study revealed correlations between RDW with systemic inflammatory biomarkers and CD8+ T-cell populations related to immune activation and exhaustion in HIV-infected individuals on ART. Further studies are warranted to determine the utility of RDW as a marker of immune dysregulation in HIV.

Indexed as

Erythrocyte IndicesT-LymphocytesAnti-Retroviral AgentsBiomarkersCross-Sectional StudiesErythrocytesFemaleHawaiiHIV InfectionsHumansInflammationMaleMiddle AgedViral LoadAnti-Retroviral AgentsBiomarkershuman immunodeficiency virusimmune activation and exhaustionimmune checkpointinflammatory biomarkerred blood cell distribution widthT cell dysregulation

Identifiers

PMID30422099
PMCPMC6324948
OpenAlexW2900951225

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.